Is Nature Reviews Molecular Cell Biology Indexed in PubMed? Yes, With Active MEDLINE Coverage
Nature Reviews Molecular Cell Biology is indexed in PubMed and currently indexed for MEDLINE, with searchable coverage beginning from volume 1, issue 1 in October 2000.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Nature Reviews Molecular Cell Biology at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 90.2 puts Nature Reviews Molecular Cell Biology in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~5-10% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Nature Reviews Molecular Cell Biology takes ~~60-90 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
Quick answer: yes.
Nature Reviews Molecular Cell Biology is indexed in PubMed, currently indexed for MEDLINE, and searchable from volume 1, issue 1 in October 2000. That matters because review journals in cell and molecular biology depend on long-term reuse.
A paper here needs to be easy to rediscover when readers search by pathway, organelle, signaling axis, or mechanism years after publication.
Direct answer
If you publish a review in Nature Reviews Molecular Cell Biology, the article is discoverable in PubMed and the journal remains actively indexed for MEDLINE.
NLM field | What the record shows | Why it matters |
|---|---|---|
publication start year | 2000 | the title has long-running continuity |
PubMed coverage | v1n1, Oct. 2000- | searchable coverage starts from the first issue |
MEDLINE coverage | v1n1, Oct. 2000- | the journal sits inside the curated NLM journal index |
current indexing status | Currently indexed for MEDLINE | this is active indexing, not leftover archive presence |
current subset | Index Medicus | the title sits inside the standard biomedical indexing structure |
NLM subject cues | Cells; Molecular Biology | the record reflects how the review will be discovered |
That is the practical answer. The journal is visible in PubMed, active in MEDLINE, and searchable continuously from launch.
Why this matters for Nature Reviews Molecular Cell Biology
The value of a review in this journal is reuse. The strongest pieces often need to reach:
- cell biologists entering a topic
- mechanism-focused labs across adjacent fields
- trainees building conceptual maps
- grant and review authors assembling foundational references
- researchers who search by process rather than by journal brand
Those readers typically search by pathway, organelle, signaling axis, or molecular mechanism. PubMed indexing matters because it helps the review reappear inside that search workflow long after publication.
For review titles, discoverability is part of the product. The article has to keep paying back by being easy to find when people need a synthesis, not only when it first appears.
What the indexing record tells you in practice
Practical question | What the record tells you |
|---|---|
will a published review be easy to find in molecular and cell biology search workflows? | yes |
is the title actively indexed for MEDLINE? | yes |
does searchable coverage begin from launch? | yes |
does indexing prove your piece is right for a review-led flagship? | no |
does indexing tell you whether the article is broad or synthetic enough? | no |
That last distinction matters because the database answer is easier than the editorial-model answer.
PubMed versus MEDLINE for Nature Reviews Molecular Cell Biology
- PubMed means the review is visible in the main biomedical search interface.
- MEDLINE means the journal remains part of the curated NLM journal index.
- Index Medicus indicates the title sits inside the standard biomedical indexing structure.
For this journal, PubMed and MEDLINE start together, so the indexing story is clean. The important thing is not the date split. It is the fact that the review remains easy to rediscover through core biomedical search.
How this compares with nearby journals
Journal pattern | What the indexing record usually supports | What it does not solve |
|---|---|---|
Nature Reviews Molecular Cell Biology | broad discoverability for synthesis pieces in cell and molecular biology | whether the article is invited or broad enough |
primary-research titles like Molecular Cell | strong discoverability for mechanistic research | whether a review format is the right vehicle |
narrower review venues | visibility inside one process or subfield | cross-topic flagship review reach |
general biology journals | field visibility for research papers | whether a synthesis piece is shaped correctly for a reviews title |
This is the useful submission implication. Indexing is not the limiting factor for this journal. Commissionability, synthesis quality, and breadth are the limiting factors.
How to verify the indexing record yourself
If you want to check this directly, the process is short:
- open the NLM Catalog record
- confirm the PubMed and MEDLINE coverage lines
- confirm Current Indexing Status
- confirm the Current Subset line
- run a direct PubMed journal search for recent articles
- compare those results with the official journal site
That manual check is useful because it confirms that the discoverability story is clean from launch and not dependent on a later indexing event.
What we see in PubMed-Indexing Questions for Nature Reviews Molecular Cell Biology
For PubMed-indexing questions for Nature Reviews Molecular Cell Biology, three patterns come up repeatedly.
The review-versus-primary-article confusion. Authors sometimes ask about PubMed indexing when the real question is whether they are holding a proper review-journal article instead of a research-style narrative. Indexing does not answer that.
The visibility-equals-fit shortcut. We also see authors assume that because the journal is highly visible in PubMed, any strong literature overview is a realistic target. That is not how review-led flagships work. Visibility does not replace commissionability or breadth.
The rediscovery blind spot. Another common miss is underestimating how much review influence depends on repeated retrieval. For this title, PubMed visibility is not a minor metadata detail. It is part of the journal’s actual infrastructure value.
What indexing does and does not tell you
This page answers the discoverability question. It does not answer whether your piece belongs in Nature Reviews Molecular Cell Biology.
Indexing tells you:
- the published review will be visible in biomedical search
- the title is actively indexed for MEDLINE
- searchable coverage begins from the first issue
Indexing does not tell you:
- whether the article is broad enough for the journal
- whether the piece is likely to be invited or welcomed
- whether a primary-research or narrower review venue is more realistic
That is why the better next reads are:
If the fit question is what you actually need answered, a Nature Reviews Molecular Cell Biology submission readiness check gives you a manuscript-specific signal before you submit.
What the NLM record means in practice for authors
The useful part of this record is not merely that the journal appears in PubMed. It is that the discoverability story is clean from launch and aligned with how synthesis literature in cell biology actually gets used.
The title begins in 2000, and the searchable PubMed and MEDLINE coverage begins there as well. That means a review published here is designed to remain easy to find whenever readers come back to a mechanism, pathway, or organelle question.
The NLM subject cues of cells and molecular biology also fit the journal’s real role. This is a synthesis venue for core conceptual biology, not a disease-specific review title. That makes PubMed discoverability especially useful because readers search by process and mechanism, not by the review-journal brand alone.
Submit If / Think Twice If
Use this indexing answer as enough reassurance if:
- your main concern is whether a published review will be easy to rediscover in cell and molecular biology search workflows
- you want confirmation that the title remains actively indexed for MEDLINE
- you need a clean citation showing searchable coverage from launch
Think twice if:
- you are using PubMed inclusion as a shortcut for review-journal fit
- the piece may still read more like a primary research story than a broad synthesis
- what you actually need is a format-and-scope judgment rather than a database-status answer
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Practical verdict
Yes, Nature Reviews Molecular Cell Biology is indexed in PubMed and currently indexed for MEDLINE, with searchable coverage from volume 1, issue 1 in October 2000.
If your question is whether a published review will be visible in the main biomedical search workflow, the answer is clearly yes. If your real question is whether your article is shaped correctly for a review-led flagship venue, that is the harder fit call. A Nature Reviews Molecular Cell Biology submission readiness check is the best next step if you want that answer before submission.
Frequently asked questions
Yes. Nature Reviews Molecular Cell Biology is indexed in PubMed and currently indexed for MEDLINE according to the NLM Catalog.
The NLM Catalog shows PubMed and MEDLINE coverage from volume 1, issue 1 in October 2000.
Because major review articles in cell and molecular biology are usually rediscovered by pathway, organelle, signaling, or mechanism search rather than by journal browsing.
Open the journal’s NLM Catalog record, confirm the PubMed and MEDLINE coverage lines plus current indexing status, then run a direct PubMed journal search for recent articles.
Sources
- 1. Nature Reviews Molecular Cell Biology NLM Catalog record, NLM.
- 2. NLM Catalog help: current indexing status, NLM.
- 3. Nature Reviews Molecular Cell Biology journal page, Springer Nature.
- 4. Nature Reviews Molecular Cell Biology author instructions, Springer Nature.
- 5. Nature Reviews Molecular Cell Biology in PubMed, PubMed.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
- Nature Reviews Molecular Cell Biology Submission Guide: What to Prepare Before You Pitch
- How to Avoid Desk Rejection at Nature Reviews Molecular Cell Biology
- Is Nature Reviews Molecular Cell Biology a Good Journal? A Real Fit Verdict for Authors
- Nature Reviews Molecular Cell Biology 'Under Consideration': What the Status Means
- Nature Reviews Molecular Cell Biology Review Time: What Authors Can Actually Expect
- Is Your Paper Ready for Nature Reviews Molecular Cell Biology? How Editors Actually Decide
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.